925 followers
New article: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies https://t.co/FjVtCf17mh #AML #leusm #hematology https://t.co/DHwC74lV44
925 followers
New article: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies https://t.co/C93GwDY7dz #AML #leusm #hematology https://t.co/xufYsehIFl
1,026 followers
17,566 followers
2,963 followers
Patterns of Resistance Differ in Patients with AML Treated with Type I versus Type II FLT3-inhibitors. #leusm #HemOnc https://t.co/xxYnDQ5tA9 Related commentary: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies. https:/
17,566 followers
2,963 followers
Patterns of Resistance Differ in Patients with AML Treated with Type I versus Type II FLT3-inhibitors. #leusm #HemOnc https://t.co/PN3tv3Su6q Related commentary: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies. https:/
22,365 followers
1,804 followers
1,380 followers
2,345 followers
482 followers
6,819 followers
3,052 followers
19,436 followers
17,566 followers
650 followers
2,963 followers
Patterns of Resistance Differ in Patients with AML Treated with Type I versus Type II FLT3-inhibitors. #leusm #HemOnc https://t.co/I6FSh0qjEZ Related commentary: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies. https:/
6,819 followers
738 followers
RT @sanamloghavi: new pub alert 🚨 Learn more about the patterns of resistance in AML treated with FLT3i #leusm @AAlotaibi_MD @musayilmaz54…
840 followers
200 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
3,339 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
3,305 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
615 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
2,963 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
2,021 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
878 followers
163 followers
17,566 followers
RT @sanamloghavi: new pub alert 🚨 Learn more about the patterns of resistance in AML treated with FLT3i #leusm @AAlotaibi_MD @musayilmaz54…
17,566 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
3,785 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
19,436 followers
new pub alert 🚨 Learn more about the patterns of resistance in AML treated with FLT3i #leusm @AAlotaibi_MD @musayilmaz54 @doctorpemm @TapKadia @kanagalshamanna @Lisa_Palacios @LeukemiaMDA @Daver_Leukemia #hemepath #hemepathMDA
4,306 followers
4,306 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
121 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
323 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
738 followers
738 followers
RT @Daver_Leukemia: Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechani…
4,692 followers
Proud to see this out in Blood Cancer Discovery :-). We need all the FLT3i we can get to overcome the different mechanisms of resistance @AAlotaibi_MD @musayilmaz54 @doctorpemm @TapKadia @sanamloghavi @kanagalshamanna @Lisa_Palacios @LeukemiaMDA
649 followers
2,963 followers
ICYMI: Patterns of Resistance Differ in Patients with AML Treated with Type I versus Type II FLT3-inhibitors. #leusm #HemOnc https://t.co/oA1Fem4EHO Related commentary: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies.
2,963 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
323 followers
RT @BCD_AACR: #OnlineFirst and at #ASH20: Resistance Patterns Differ in AML Patients Treated with Type I versus Type II FLT3-inhibitors. h…
1,841 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
22,147 followers
RT @_TanyaBondar_: And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @a…
4,692 followers
RT @_TanyaBondar_: And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @a…
323 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
4,692 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
233 followers
RT @BCD_AACR: #OnlineFirst and at #ASH20: Resistance Patterns Differ in AML Patients Treated with Type I versus Type II FLT3-inhibitors. h…
3,153 followers
RT @_TanyaBondar_: And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @a…
1,841 followers
RT @_TanyaBondar_: And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @a…
738 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
726 followers
RT @LugoMd: Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mut…
738 followers
RT @_TanyaBondar_: And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @a…
233 followers
Happy to share the recently published paper @BCD_AACR presented at #ASH20 @AAlotaibi_MD @Daver_Leukemia where they describe mutations that emerge at relapse after FLT3-i Tx https://t.co/s4PGtxzxy7, and check our commentary @aditishasMD @Amitvermamds https:
658 followers
And check the accompanying commentary on this work and Beat AML trial by Drs. Amit Verma @vermalab1 and Aditi Shastri @aditishasMD: https://t.co/GagyRqkXq1. Thank you!!! @LeukemiaMDA @CancerMedMDA @MontefioreNYC @EinsteinMed #ASH20 #leusm #HemOnc
2,963 followers
#OnlineFirst and at #ASH20: Resistance Patterns Differ in AML Patients Treated with Type I versus Type II FLT3-inhibitors. https://t.co/dJDpISgrrW Related commentary: Understanding FLT3 Inhibitor Resistance to Rationalize Combinatorial AML Therapies. ht